Researchers May Now Predict Which CLL Patients Will Respond to Kymriah CAR T-Cell Therapy, Study Says – Immuno-Oncology News
Immuno-Oncology News |
Researchers May Now Predict Which CLL Patients Will Respond to Kymriah CAR T-Cell Therapy, Study Says
Immuno-Oncology News This immuno-oncology treatment is developed using the patient's own T-cells to target proteins located on the surface of cancer cells. Researchers from the Perelman School of Medicine at the University of Pennsylvania (Penn Medicine) and Novartis have … |
